Challenge-mig: a phase 4, randomized, double-blind, double-dummy study comparing the efficacy and safety of galcanezumab versus rimegepant for prevention of episodic migraine

Saved in:
Bibliographic Details
Published inJournal of the neurological sciences Vol. 455; p. 121116
Main Authors Schwedt, Todd J., Myers Oakes, Tina M., Martinez, James M., Vargas, Bert B., Pandey, Hitendra N., Pearlman, Eric M., Richardson, Diane R., Varnado, Oralee J., Meyer, Michael Cobas, Goadsby, Peter J.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.12.2023
Subjects
Neurology
Online AccessGet full text

Cover

More Information
ISSN:0022-510X
DOI:10.1016/j.jns.2023.121116